LabCompass

John A. Wildenthal

Medicine · The Ohio State University

OpenAlex ORCID
Mid career · publishing since 2016
Folate and B Vitamins ResearchAmino Acid Enzymes and MetabolismAntibiotic Resistance in BacteriaMicrobial bioremediation and biosurfactantsBreast Implant and Reconstruction

Publications

16

Citations

347

Est. group size

—

Recurring co-author estimate

Active years

10

Publishing since 2016

Research summary
AI-generated

John A. Wildenthal's research focuses on infectious diseases, spanning bacterial infections related to injection drug use, implant-associated infections after breast reconstruction surgery, and the molecular biology of bacteria such as E. coli and Staphylococcus aureus. His work often combines clinical patient outcomes with laboratory techniques like metabolomics (studying small molecules in the body) to detect or understand infections earlier and more precisely.

Infectious disease diagnostics and metabolomicsBacterial pathogenesis (E. coli, S. aureus)Injection drug use-associated infectionsImplant-associated and surgical site infectionsAntibiotic treatment outcomes

Publication output has been steady over the past decade, averaging about 1-2 papers per year with no clear upward or downward trend.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026

Publication cadence
Publications per year over the last 10 years — averaging 1.6/year recently
2017: 1 publication172018: 2 publications2182019: 1 publication192020: 2 publications2202021: 1 publication212022: 2 publications2222023: 2 publications2232024: 2 publications2242025: 2 publications22526
Recent publications
Publishes in
  • mBio×3
  • Open Forum Infectious Diseases×2
  • Science×1
  • Proceedings of the National Academy of Sciences×1
  • Clinical Infectious Diseases×1
Similar researchers
By research-topic overlap

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 19, 2026.

Claim or correct this profile